Belongs to

• Center for Hematologic Malignancies

Types of Work

["2019"]

[[["Meeting Abstracts",1789],["Journal Articles",1594],["Reviews",121],["Research Letters",54],["Editorials",48],["Book Sections",39],["Guidelines",20],["Conference Papers",18],["Correspondences",12],["Miscellaneous",3],["Book Wholes",1]]]

[3699]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• humans
• male
• nonhuman
• priority journal

Recent Works

1. Treatment patterns and real-world outcomes of molecular subgroups in patients with AML receiving frontline venetoclax-based therapy

   Journal Article

   Lachowiez, C. A.; Barcellos, A.; Zettler, C. M.; Belli, A. J.; Fernandes, L. L.; Hansen, E.; Wang, C. K.; Owusu, H. F.; Zeidan, A. M.; Stein, E. M.; more...
   JCO Oncology Practice (2025)

   Fulltext@MSK | Save
2. Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: The AUGMENT-101 study

   Journal Article

   Arellano, M. L.; Thirman, M. J.; DiPersio, J. F.; Heiblig, M.; Stein, E. M.; Schuh, A. C.; Žučenka, A.; De Botton, S.; Grove, C. S.; Mannis, G. N.; more...
   Blood (2025)

   Fulltext@MSK | Save
3. Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: A prospective, observational study–SIMPLICITY

   Journal Article

   Mauro, M. J.; Hehlmann, R.; Williams, L. A.; Goldberg, S. L.; Michallet, M.; Gambacorti-Passerini, C.; Tang, D.; DeGutis, I. S.; McBride, A.; Parsons, L.; more...
   Leukemia and Lymphoma (2025)

   Fulltext@MSK | Save